•TechnipFMC was awarded a significant contract by Eni for the Baleine Phase 3 development offshore Côte d'Ivoire.
•The contract involves designing and manufacturing flexible flowlines and risers to connect wells to a new floating production unit at 1,200 meters depth.
•Organogenesis announced that the FDA has accepted for review its Biologics License Application (BLA) for ReNu, a treatment for symptomatic knee osteoarthritis.